Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Department of Pediatric Endocrinology, Children's Hospital at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Ann Behav Med. 2018 Nov 12;52(12):1010-1022. doi: 10.1093/abm/kay005.
Type 1 diabetes is associated with significant mortality and economic cost. Management of type 1 diabetes involves completing multiple daily adherence behaviors, and many adolescents struggle with self-management and show poor glycemic control.
The purpose was to conduct an unblinded pilot randomized controlled parallel-group study of a web-delivered multicomponent intervention targeting self-monitoring of blood glucose, working memory, and parent supervision of diabetes care among adolescents with type 1 diabetes. Intervention components included high magnitude incentives for adolescents and parents, motivational and cognitive behavioral therapy and working memory training for adolescents, and training in contingency contracting for parents.
Adolescents (N = 114) with poorly controlled type 1 diabetes were screened, and N = 61 were randomized using minimum likelihood allocation to usual care (usual care, N = 31) or to a 25-week/15-session web-delivered intervention (WebRx, N = 30).
At the end of treatment, adolescents in WebRx had higher self-monitoring of blood glucose (d = 0.58) (primary outcome), better visual spatial working memory (d = 0.48) and inhibition (d = 0.98), and lower HbA1c (d = 0.45) than those in usual care. WebRx parents reported more frequent review of the adolescent's glucometer (d = 1.30) and reduced family conflict (d = 0.56). Between-condition differences were maintained 6 months later in self-monitoring of blood glucose (d = 0.42), visual spatial working memory (d = 0.76), family conflict (d = 0.50), and HbA1c (d = 0.44).
Results showing sustained effects on self-monitoring of blood glucose and HbA1c support moving forward with a larger trial to test this innovative web-delivered and multicomponent intervention. ClinicalTrials.gov Number (NCT01722643).
1 型糖尿病与显著的死亡率和经济成本相关。1 型糖尿病的管理涉及完成多项日常依从性行为,许多青少年在自我管理方面存在困难,血糖控制不佳。
旨在对一项针对 1 型糖尿病青少年自我监测血糖、工作记忆和父母监督糖尿病护理的网络多组分干预措施进行非盲试点随机对照平行组研究。干预措施包括为青少年和父母提供高幅度激励、针对青少年的动机和认知行为疗法以及工作记忆训练,以及为父母提供应急合同培训。
对血糖控制不佳的 114 名青少年进行了筛选,其中 61 名青少年采用最小似然分配随机分为常规护理组(常规护理组,n=31)或 25 周/15 次网络干预组(WebRx,n=30)。
在治疗结束时,WebRx 组青少年的自我监测血糖(d=0.58)(主要结局)、视觉空间工作记忆(d=0.48)和抑制(d=0.98)更好,HbA1c(d=0.45)更低,而常规护理组青少年则更低。WebRx 组父母报告青少年血糖仪检查更频繁(d=1.30),家庭冲突减少(d=0.56)。在 6 个月后,自我监测血糖(d=0.42)、视觉空间工作记忆(d=0.76)、家庭冲突(d=0.50)和 HbA1c(d=0.44)的组间差异仍保持不变。
结果显示自我监测血糖和 HbA1c 的持续效果支持进一步进行更大规模的试验,以测试这种创新的网络多组分干预措施。临床试验注册编号(NCT01722643)。